Evaluating the impact of delayed study startup on accrual in cancer studies
Longer activation times are associated with lower project success, and early-phase studies tend to be more successful than late-phase studies. Therefore, by reducing impediments to the approval process, we can facilitate quicker approvals, increasing the success of studies regardless of phase.
Authors
- Byron J. Gajewski (ORCID: https://orcid.org/0000-0001-7589-8247)
- Natalie Streeter (ORCID: https://orcid.org/0000-0003-3309-1992)
- Dinesh Pal Mudaranthakam (ORCID: https://orcid.org/0000-0001-9767-1158)
- Tara L. Lin (ORCID: https://orcid.org/0000-0002-0242-6449)
- Oluwatobiloba Ige (ORCID: https://orcid.org/0009-0003-3953-1992)
- Sam Pepper (ORCID: https://orcid.org/0000-0003-0696-3820)
- Matthew McGuirk
- Isuru Panduka Ratnayake (ORCID: https://orcid.org/0000-0001-9596-781X)
- Daniel A. Gajewski
- Anh-Tuan Do
Institutions
- Rockhurst University (US)
- The University of Kansas Cancer Center (US)
- University of Kansas Medical Center (US)
Publication Details
- Journal
- Contemporary Clinical Trials Communications
- Published
- 2025-10-25
- DOI
- https://doi.org/10.1016/j.conctc.2025.101562
- Primary Topic
- Ethics in Clinical Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00